The Kawasaki Disease Comparative Effectiveness (KIDCARE) trial: A phase III, randomized trial of second intravenous immunoglobulin versus infliximab for resistant Kawasaki diseaseSamantha C. Roberts, Sylvia H. Yeh, Marsha S. Anderson et al.|Contemporary Clinical Trials|2019Cited by 25
Population Pharmacokinetics and Safety of Solithromycin following Intravenous and Oral Administration in Infants, Children, and AdolescentsDaniel González, Michael Cohen‐Wolkowiez, Laura P. James et al.|Antimicrobial Agents and Chemotherapy|2018Cited by 5
The Kawasaki Disease Comparative Effectiveness (KIDCARE) trial: A phase III, randomized trial of second intravenous immunoglobulin versus infliximab for resistant Kawasaki diseaseSamantha C. Roberts, Sylvia H. Yeh, Sonia Jain et al.|Author eBooks|2019Cited by 1